Skip to main content

Healthcare

Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories

January 12, 2021
Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners, announced today the acquisition of Mosaic Laboratories LLC, a California-based company offering histology and immunohistochemistry services to global pharmaceutical clients.
Read More about Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories

Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO

January 7, 2021
Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners, announced today the acquisition of Clinical Logistics Inc. ("CLI"), a Virtual Central Specimen Management CRO based in Halifax, Canada.
Read More about Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO

Arsenal Capital Partners Acquires Best Value Healthcare

November 17, 2020
Arsenal Capital Partners, a private equity firm that specializes in investments in healthcare and specialty industrial companies, has acquired Best Value Healthcare LLC in partnership with its founders:  Raj Naik, M.D., Kimberly Ficocelli, and Dillon Moore.  Best Value is a leading primary care platform focused on Medicare Advantage and operating in Central and South Florida.  The terms of the transaction were not disclosed.
Read More about Arsenal Capital Partners Acquires Best Value Healthcare

symplr to acquire TractManager

October 23, 2020
symplr, a leading global healthcare governance, risk management, and compliance software-as-a-service platform, backed by Clearlake Capital Group, L.P. and SkyKnight Capital, today announced that it has signed a definitive agreement to acquire TractManager from Arsenal Capital Partners.
Read More about symplr to acquire TractManager

Arsenal Capital Partners Adds Dr. Richard Eglen as Senior Advisor to its Healthcare Team

September 23, 2020
Arsenal Capital Partners, a private equity firm that specializes in investments in healthcare and industrial companies, today announced its partnership with Dr. Richard Eglen as a Senior Advisor to its healthcare team.  Dr. Eglen will work with Arsenal’s healthcare team to further develop life science tools and reagents investment themes.  He will also serve as both a member of the Scientific Advisory Board and an advisor to the Board of Directors of BioIVT, an Arsenal portfolio company that is a global leader in providing in vitro research models and services for drug and diagnostic development.
Read More about Arsenal Capital Partners Adds Dr. Richard Eglen as Senior Advisor to its Healthcare Team
Subscribe to Healthcare